# The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)

> **NCT02231632** · PHASE2,PHASE3 · COMPLETED · sponsor: **Institute of Medical Biology, Chinese Academy of Medical Sciences** · enrollment: 1200 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Live attenuated Poliomyelitis vaccine (Human Diploid Cell)
- **BIOLOGICAL:** Live attenuated Poliomyelitis vaccine (Monkey Kidney Cell)

## Key facts

- **NCT ID:** NCT02231632
- **Lead sponsor:** Institute of Medical Biology, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-08
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2023-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231632, "The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02231632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*